register

News & Trends - Pharmaceuticals

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health policy is set to transform over the next 10-15 years to better serve consumers and wider stakeholders, including industry.

Prioritising “prevention and healthcare as an investment” are essential in paving the way for Australians to lead “longer, more productive and healthier lives”, according to Zeller.

Reflecting on his extensive international experience, Zeller highlighted the significant challenges and roadblocks that hinder the development of a long-term strategic vision for health policy.

“There are a massive amount of competing priorities, and so everybody has their entrenched positions… It begs the question, what are we solving for?” he questioned.

Zeller emphasised the crucial role of industry in shaping the conversation around local health policy to address the barriers that still exist.

“We sometimes don’t do a good job as an industry of aligning what we want. We have a role in creating data and metrics that can bring sense to the conversation, and we need to add more uniformity and pragmatism to the discussion,” he highlighted.

Drawing on lessons from other countries, including Estonia, Germany, Hungary and the UK, Zeller identified best practices and strategies that Australia could adopt to enhance its health policy framework.

In conclusion, Zeller outlined key short-term actions, including the need for a “well-executed” response to the HTA review from the government and the appetite for “experimentation” that are essential for steering towards the reimagined future of health policy.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Department of Health review reveals mixed results on minimum stockholding policy

Department of Health review reveals mixed results on minimum stockholding policy

Health Industry Hub | August 29, 2024 |

Pharma News: The Department of Health has concluded a 12-month review of the Minimum Stockholding Requirements (MSR) policy, assessing its […]

More


News & Trends - Pharmaceuticals

AstraZeneca-Daiichi Sankyo targeted therapy listed on the PBS in advanced breast cancer

AstraZeneca-Daiichi Sankyo targeted therapy listed on the PBS in advanced breast cancer

Health Industry Hub | August 29, 2024 |

Pharma News: Breast cancer, the second most diagnosed cancer in Australia and the leading cancer among women, affects around 58 […]

More


News & Trends - Pharmaceuticals

Leadership homecoming at Organon ANZ: New country head returns to steer future growth

Leadership homecoming at Organon ANZ: New country head returns to steer future growth

Health Industry Hub | August 29, 2024 |

Pharma News: Organon has announced the appointment of Bilal Somra as the new Country Lead for Australia and New Zealand […]

More


News & Trends - Pharmaceuticals

Sandoz secures regulatory approval for first biosimilar to Amgen's Prolia

Sandoz secures regulatory approval for first biosimilar to Amgen’s Prolia and Xgeva

Health Industry Hub | August 28, 2024 |

Pharma News: Sandoz ANZ has secured regulatory approval for its denosumab biosimilars, Jubbonti and Wyost, for the treatment of osteoporosis […]

More


This content is copyright protected. Please subscribe to gain access.